TABLE 1.
Variable | Factor | |||
---|---|---|---|---|
1 | 2 | 3 | 4 | |
ITG Daytime Symptoms Score | 0.804 | |||
ITG Nighttime Symptoms Score | 0.842 | |||
ITG Functional Limitations Score | 0.818 | |||
Asthma Control Test™ | 0.723 | |||
Post-bronchodilator FEV1, % predicted | 0.719 | |||
Post-bronchodilator FEF25-75, % predicted | 0.783 | |||
Post-bronchodilator FEV1/FVC, % predicted | 0.858 | |||
Nasal eosinophils, % | −0.794 | |||
Nasal neutrophils, % | 0.669 | |||
Blood eosinophils, % | 0.719 | |||
Total serum IgE, IU/mL | 0.819 |
Abbreviations: ITG = Integrated Therapeutics Group’s Child Asthma Short Form; IgE = Immunoglobulin E
All factors had Eigenvalues >1
The KMO measure of sampling adequacy was 0.700
The Bartlett test of sphericity had a significance of <0.001
Communality of all variables was 100%
> 65% of the total variance was explained by the factors